A detailed history of Hemenway Trust CO LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hemenway Trust CO LLC holds 10,956 shares of NVO stock, worth $957,225. This represents 0.11% of its overall portfolio holdings.

Number of Shares
10,956
Previous 11,388 3.79%
Holding current value
$957,225
Previous $1.63 Million 19.75%
% of portfolio
0.11%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$119.07 - $145.42 $51,438 - $62,821
-432 Reduced 3.79%
10,956 $1.3 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $159,584 - $191,708
1,818 Added 19.0%
11,388 $1.18 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $424,507 - $931,452
4,668 Added 95.23%
9,570 $870,000
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $451,562 - $499,821
2,895 Added 144.25%
4,902 $793,000
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $205,817 - $271,607
2,007 New
2,007 $271,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hemenway Trust CO LLC Portfolio

Follow Hemenway Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hemenway Trust CO LLC with notifications on news.